Roche Announces It Will Begin Selling New Test To Identify Cancer Gene Mutations.

Reuters (9/24) reports Roche announced that it is ready to market a blood test called FoundationOne Liquid that can “identify common cancer gene mutations from a patient’s blood.” The company indicated its test can “identify circulating tumor DNA and ide...